• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany

tetano

Editor, Senior Moderator
PLoS One


. 2020 Nov 12;15(11):e0242127.
doi: 10.1371/journal.pone.0242127. eCollection 2020.
COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany


Siegbert Rieg[SUP] 1 [/SUP], Maja von Cube[SUP] 2 [/SUP], Johannes Kalbhenn[SUP] 3 [/SUP], Stefan Utzolino[SUP] 4 [/SUP], Katharina Pernice[SUP] 5 [/SUP], Lena Bechet[SUP] 1 [/SUP], Johanna Baur[SUP] 6 7 [/SUP], Corinna N Lang[SUP] 6 7 [/SUP], Dirk Wagner[SUP] 1 [/SUP], Martin Wolkewitz[SUP] 2 [/SUP], Winfried V Kern[SUP] 1 [/SUP], Paul Biever[SUP] 6 7 [/SUP], COVID UKF Study Group



Affiliations

Abstract

Background: Reported mortality of hospitalised Coronavirus Disease-2019 (COVID-19) patients varies substantially, particularly in critically ill patients. So far COVID-19 in-hospital mortality and modes of death under state of the art care have not been systematically studied.
Methods: This retrospective observational monocenter cohort study was performed after implementation of a non-restricted, dynamic tertiary care model at the University Medical Center Freiburg, an experienced acute respiratory distress syndrome (ARDS) and extracorporeal membrane-oxygenation (ECMO) referral center. All hospitalised patients with PCR-confirmed SARS-CoV-2 infection were included. The primary endpoint was in-hospital mortality, secondary endpoints included major complications and modes of death. A multistate analysis and a Cox regression analysis for competing risk models were performed. Modes of death were determined by two independent reviewers.
Results: Between February 25, and May 8, 213 patients were included in the analysis. The median age was 65 years, 129 patients (61%) were male. 70 patients (33%) were admitted to the intensive care unit (ICU), of which 57 patients (81%) received mechanical ventilation and 23 patients (33%) ECMO support. Using multistate methodology, the estimated probability to die within 90 days after COVID-19 onset was 24% in the whole cohort. If the levels of care at time of study entry were accounted for, the probabilities to die were 16% if the patient was initially on a regular ward, 47% if in the intensive care unit (ICU) and 57% if mechanical ventilation was required at study entry. Age ≥65 years and male sex were predictors for in-hospital death. Predominant complications-as judged by two independent reviewers-determining modes of death were multi-organ failure, septic shock and thromboembolic and hemorrhagic complications.
Conclusion: In a dynamic care model COVID-19-related in-hospital mortality remained very high. In the absence of potent antiviral agents, strategies to alleviate or prevent the identified complications should be investigated. In this context, multistate analyses enable comparison of models-of-care and treatment strategies and allow estimation and allocation of health care resources.
 
Back
Top Bottom